David Pass is the founder of Gelesis. Gelesis has raised $5M in total funding. Latest round: Series A. Based in Lowell, USA.
David Pass, PharmD, is the president and chief executive officer of AltrixBio. He brings decades of leadership experience across the pharmaceutical, biotech and medical device sectors. Prior to AltrixBio, he served as president of Life Sciences at Glooko.
Full founder directory · Investor directory · Company funding database · Fundraising library